Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes
Imported from official source
20 August 2026 The South African Health Products Regulatory Authority (SAHPRA) wishes to remind healthcare professionals of the risk of angioedema during treatment with angiotensin-converting enzyme (ACE) inhibitors (e.g. captopril, enalapril, lisinopril, perindopril, quinapril, ramipril, trandolapril). Healthcare professionals are reminded that ACE inhibitor treatment should... …
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:35
- Change
- Initial
- Content hash
8876ac831c3783cf4932b1bd856bf7b7- All versions
- Revision history